Despite recessive mutations often resulting in the complete loss of α1 subunit expression (14) and dominant-negative mutations often involving only moderate disruption to α1 subunit function, there is no evidence for “major” or “minor” forms of hyperekplexia and no evidence for a ...
8. A testing reagent for detection of Aggrus expression, comprising a neutralizing monoclonal antibody or a fragment consisting of a functional fragment thereof according to claim 1.Description: TECHNICAL FIELD The present invention relates to a region of Aggrus involved in the binding to CLEC-2,...